Oprometria

P&T DIGEST
A PEER-REVIEWED COMPENDIUM OF FORMULARY CONSIDERATIONS

DRY EYE SYNDROME
• Historical
perspectives
• Prevalence
and economic
implications
• Etiology of disease
• 2003 AAO
guidelines
for treatment
• Drug-therapy
review
• Pharmacoeconomic
data

Continuing education credit for physicians and pharmacists
sponsored by The Chatham Institute

• Proper
medication useSUPPLEMENT TO

M

A

N

A

G

E

D

Care
Vol. 12, No. 12
December 2003

This program is supported by an educational grant
from Allergan

A B O U T T H I S P U B L I C AT I O N

P&T DIGEST
A PEER-REVIEWED COMPENDIUM OF FORMULARY CONSIDERATIONS

Chief Medical Editor
John D. Sheppard, MD, MMSc
Faculty
Eric D. Donnenfeld, MD
Richard G. Fiscella, RPh, MPH
Jan D. Hirsch,PhD
Henry D. Perry, MD
Steven E.Wilson, MD
Editor
Michael D. Dalzell
Consulting Editor
John A. Marcille
Contributing Editors
Tony Berberabe
Bob Carlson
Frank Diamond
William W. Edelman
Linda Felcone
Maxine Losseff
Jack McCain
Paula Sirois
Design Director
Philip Denlinger
Group Publisher
Timothy P. Search, RPh
Director, New Product Development
Timothy J. Stezzi
Eastern SalesManager
Scott MacDonald
Senior Account Manager
Blake Rebisz
Midwest Sales Manager
Terry Hicks
Director, Production Services
Waneta Peart
MANAGED CARE (ISSN 1062-3388) is published monthly by
MediMedia USA Inc., at 780 Township Line Road,Yardley, PA
19067.This is Volume 12, Issue 12. Periodical postage paid at
Morrisville, Pa., and at additional mailing offices. POSTMASTER: Send addresschanges to MANAGED CARE, 780 Township
Line Road,Yardley, PA 19067. Prices: $10 per copy, $93 per
year in the USA; $120 per year elsewhere. Send letters to the
editor c/o Frank Diamond, MANAGED CARE, 780 Township
Line Road,Yardley, PA 19067. Letters may be edited for length
and clarity. E-mail: editors@managedcaremag.com. Phone:
(267) 685-2788; fax (267) 685-2966; circulation inquiries (267)685-2782. Copyright ©2003 MediMedia USA Inc.

A Tool for Formulary Decision Makers

T

he understanding of keratoconjunctivitis sicca (KCS), also
known as dry eye syndrome, has changed in the past 5 years.
Until recently, it was thought to have been due to aqueous insufficiency. Today, it is understood that KCS is a multifactorial disease that also involves inflammation of the ocularsurface and
lacrimal gland, neurotrophic deficiency, and meibomian dysfunction. This change in understanding, reflected in the 2003 AAO Dry
Eye Syndrome Preferred Practice Pattern that is summarized herein,
has led to the development of new and effective medications.
This peer-reviewed publication gives physicians and pharmacists
who serve on pharmacy and therapeutics committees up-to-dateinformation about the most efficacious and cost-effective medical
treatments available. Relatively little published data exist in a centralized format about medical therapies for dry eye syndrome,
compared with information about other chronic conditions. This
publication, a digest of existing knowledge and best practices, serves
as a valuable tool for formulary decision makers and is an importantcontribution to the medical literature.

Editorial Advisory Board
John D. Sheppard, MD, MMSc
Chairman, Editorial Advisory Board and Chief Medical Editor
P&T Digest | Dry Eye Syndrome
Program Director, Department of Ophthalmology
Eastern Virginia Medical School
Norfolk, Va.
Richard G. Fiscella, RPh, MPH
Assistant Director, Clinical Services/Ambulatory Care
University of Illinois atChicago (UIC) Hospital
Department of Pharmacy
Clinical Associate Professor
UIC Department of Pharmacy Practice
Clinical Coordinator
UIC Eye and Ear Infirmary
Chicago
This publication is made possible by an educational grant from
Allergan.

P&T DIGEST
A PEER-REVIEWED COMPENDIUM OF FORMULARY CONSIDERATIONS

DRY EYE
SYNDROME
John D. Sheppard, MD, MMSc
Chief Medical Editor

P&T DIGEST...